Among the Premarket stories for Tuesday, May 6, from AP Financial News:
NEW YORK (AP) -- Despite a first quarter in which Baxter International Inc. had to recall its blood thinner heparin amid a Food and Drug Administration investigation into contamination of the product, analysts say the company is poised for growth.
NEW YORK (AP) -- Bristol-Myers Squibb Co. will hold its annual stockholder meeting Tuesday and Wall Street may be looking for further updates on the company's ongoing restructuring plan.
WASHINGTON (AP) -- Medical experts will consider Tuesday whether use of a painkiller made by Cephalon Inc. should be expanded, despite government concerns about increased risks for abuse.
NEW YORK (AP) -- Analysts expect shares of McKesson Corp. to rise Tuesday after the prescription drug distributor reported a strong fiscal fourth quarter and forecast fiscal 2009 profit mostly above expectations.
NEW YORK (AP) -- A Piper Jaffray analyst says Omniture Inc.'s marketing strategy is working and sales are strong, and he upgraded the analytic software company's stock to "Buy" from "Neutral."![]()



